Document Detail


Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital.
MedLine Citation:
PMID:  2048399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Serum lipids, lipoproteins and apolipoproteins A and B were measured in 101 epileptic patients receiving chronic treatment with valproic acid, carbamazepine or phenobarbital and in 75 age- and sex-matched control subjects. In relation to controls, subjects treated with valproic acid showed significantly lower values of total and LDL-cholesterol levels; subjects treated with carbamazepine showed significantly higher values of HDL-cholesterol and apolipoprotein A concentrations and subjects treated with phenobarbital showed significantly higher values of total cholesterol, HDL-cholesterol, apolipoprotein A and apolipoprotein B levels. The total cholesterol/HDL-cholesterol ratio was significantly lower in patients receiving valproic acid or carbamazepine but not in the phenobarbital-treated group. Changes in serum lipids profile did not correlate with drug plasma concentrations nor the duration of the treatment.
Authors:
E P Calandre; C Rodriquez-Lopez; A Blazquez; D Cano
Related Documents :
21530799 - All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide pro...
8480679 - Marked increase in plasma high-density-lipoprotein cholesterol after prolonged fasting ...
2897239 - Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components i...
21270369 - Adherence index based on the aha 2006 diet and lifestyle recommendations is associated ...
17144439 - Effects of tomatoes on the lipid profile.
9710659 - Medical nutrition therapy lowers serum cholesterol and saves medication costs in men wi...
19307649 - Metabolism and lactation performance in dairy cows fed a diet containing rumen-protecte...
7735589 - Dietary antioxidant vitamin intake and lung function in the general population.
3080429 - Methionine metabolism in mammals. adaptation to methionine excess.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  83     ISSN:  0001-6314     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-07-16     Completed Date:  1991-07-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  250-3     Citation Subset:  IM    
Affiliation:
Clinical Pharmacology Department, University Hospital, Granada, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Analysis of Variance
Apolipoproteins A / blood
Apolipoproteins B / blood
Carbamazepine / therapeutic use*
Child
Child, Preschool
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Cholesterol, VLDL / blood
Epilepsy / blood*,  drug therapy*
Female
Humans
Lipids / blood*
Male
Middle Aged
Phenobarbital / therapeutic use*
Valproic Acid / therapeutic use*
Chemical
Reg. No./Substance:
0/Apolipoproteins A; 0/Apolipoproteins B; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Cholesterol, VLDL; 0/Lipids; 298-46-4/Carbamazepine; 50-06-6/Phenobarbital; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term observations on calcium accumulation in postischemic gerbil brain.
Next Document:  Outcome following occlusion of the middle cerebral artery.